Bajaj Healthcare Limited

BSE: BAJAJHCARE539872ISIN INE411U01027

Healthcare
Pharmaceuticals
BSE Healthcare

BSE listing

Share price

₹329.05+0.50 (+0.15%)

as of 18 Sep 2026

52W high: ₹516.20
52W low: ₹272.45
Off 52W high: -36.26%
1M return: +3.02%
3M return: +5.20%
6M return: +4.98%
1Y return: -22.91%
20D avg volume: 10,610
50 DMA: ₹332.96
200 DMA: ₹342.30

Key ratios Standalone

Market cap: ₹1,108 Cr
Current price: ₹329.05
52W high / low: ₹516.20 / ₹272.45
Face value: ₹5.00
P/E: 62.80
P/B: 2.48
EPS (TTM): ₹5.24
Book value / share: ₹132.68
ROE: 3.95%
ROCE: 8.50%
Operating margin: 17.85%
Net margin: 8.27%
Debt / equity: 0.44
Net debt: ₹196.23 Cr
Interest cover: 2.30
Dividend yield: 0.76%
Dividend / share (TTM): ₹2.50
Payout: 47.71%
Cash conversion cycle: 199.8 days

Financials

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q4 FY24
Income statement
	165.63	153.06	161.22	147.91	148.84	154.47	—
	0.81	2.96	1.65	1.65	0.88	13.57	—
	149.98	143.58	143.63	133.61	135.19	156.32	—
	91.59	92.10	69.41	74.81	69.88	100.49	—
	0.00	0.00	0.00	0.00	0.00	0.00	—
	17.47	16.30	15.59	16.51	14.36	15.71	—
	6.09	5.57	5.88	5.56	5.23	6.08	—
	7.01	7.63	7.20	7.08	5.64	7.53	—
	33.31	32.57	34.26	30.86	29.38	33.04	—
	16.46	12.44	19.24	15.96	14.53	11.72	—
	0.00	-33.25	0.00	0.00	0.00	0.00	—
	16.46	-20.81	19.24	15.96	14.53	11.72	—
	2.57	-1.40	3.14	3.51	2.35	0.13	—
	13.70	-22.85	15.67	11.11	11.83	11.18	—
	4.07	-7.16	4.96	3.53	3.74	3.54	—
Key metrics
	29.56	-7.61	32.32	28.60	25.40	25.33	—
	17.80%	-5.00%	20.00%	19.30%	17.10%	16.40%	—
	8.30%	-14.90%	9.70%	7.50%	7.90%	7.20%	—
	—	-2.50%	—	3.80%	—	3.20%	—
	11.30%	-0.90%	—	—	—	—	—
	15.80%	-304.40%	—	—	—	—	—

Metric	TTM	FY26	FY25	FY24
Income statement
	627.82	611.03	542.60	—
	7.07	7.13	19.40	—
	570.80	556.00	516.00	—
	327.91	306.20	307.11	—
	0.00	0.00	0.00	—
	65.87	62.75	57.06	—
	23.10	22.23	27.90	—
	28.92	27.55	27.92	—
	131.00	127.07	116.67	—
	64.10	62.17	46.01	—
	-33.25	-33.25	0.00	—
	30.85	28.92	46.01	—
	7.82	7.61	3.08	—
	17.63	15.77	39.50	—
	5.40	4.98	13.29	—
Key metrics
	82.87	78.70	101.83	—
	13.20%	12.90%	18.80%	—
	2.81%	2.60%	7.30%	—
	—	8.50%	13.20%	—
	—	12.60%	—	—
	—	-60.10%	—	—
	—	14.73	10.08	—
	—	3.68	0.55	—
	—	0.44	0.48	—
	—	196.23	220.03	—
	—	199.8	214.0	—
Balance sheet
	—	923.22	833.05	—
	—	569.08	485.40	—
	—	37.24	2.60	—
	—	233.85	251.67	—
	—	216.01	161.89	—
	—	76.00	33.96	—
	—	247.22	236.56	—
	—	115.28	95.47	—
	—	319.56	272.27	—
	—	233.47	222.63	—
	—	185.90	157.96	—
	—	47.57	64.67	—
	—	533.00	466.16	—
Cash flow
	—	58.08	21.62	—
	—	-47.78	-14.82	—
	—	24.33	-6.38	—
	—	43.35	11.54	—

Compounded growth

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Sales CAGR 10Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Profit CAGR 10Y: —
Sales YoY (TTM): —
Profit YoY (TTM): —

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Jun 2026

Promoter holding: 58.59%

Holder	Type	Holding	Previous	Change
SAJANKUMAR RAMESHWARLAL BAJAJ	Promoter	36.62%	—	—
ANIL CHAMPALAL JAIN	Promoter Group	6.05%	—	—
NAMRATA BAJAJ	Promoter Group	4.85%	—	—
NIHITA BAJAJ KUMAR	Promoter Group	4.81%	—	—
BABITA SAJANKUMAR BAJAJ	Promoter Group	4.47%	—	—
DEEPAK RAMANLAL JOSHI	Public	2.32%	—	—
HDFC MUTUAL FUND - HDFC PHARMA AND HEALTHCARE FUND	Public	1.69%	—	—
PADMA ANIL JAIN	Promoter Group	0.90%	—	—
BAJAJ HEALTH AND NUTRITIONS LLP	Promoter Group	0.71%	—	—
BANSAL PHARMA LIMITED	Promoter Group	0.18%	—	—
SKR BAJAJ HUF	Promoter Group	0.00%	—	—

Public shareholders are disclosed individually only above 1%.

Filings & corporate actions

Recent announcements

Intimation of Record Date for the payment of Final Dividend for the financial year 2025-263 Sep 2026 · Corp. Action / Record Date
Intimation for newspaper publication- Dispatch of Notice of 33rd Annual General Meeting and Annual Report for the financial year 2025-2630 Aug 2026 · Company Update / Newspaper Publication
Intimation for Inland Letters sent to Shareholders29 Aug 2026 · AGM/EGM / AGM
Intimation for Business Responsibility and Sustainability Report for the financial year 2025-2629 Aug 2026 · Others / Business Responsibility and Sustainability Reporting (BRSR)
Intimation of the Annual Report for the financial year 2025-2629 Aug 2026 · Others / Reg. 34 (1) Annual Report
Intimation of 33rd Annual General Meeting and dispatch of Annual Report of the Company for the financial year 2025-2629 Aug 2026 · AGM/EGM / AGM
Intimation for Newspaper Publication with respect to 33rd Annual General Meeting of the Company26 Aug 2026 · Company Update / Newspaper Publication
Intimation of allotment of equity shares pursuant to exercise of ESOPs21 Aug 2026 · Company Update / Allotment of ESOP / ESPS
The Company has received the approval from DCGI to manufacture and market Cenobamate API and Tablets12 Aug 2026 · Company Update / General
Revision in Credit Rating6 Aug 2026 · Company Update / Credit Rating
Transcript of Earnings Call for Q1FY2727 Jul 2026 · Company Update / Earnings Call Transcript
Intimation for Newspaper Publication22 Jul 2026 · Company Update / Newspaper Publication
Intimation for Audio Recording of Earnings Call for Q1FY2721 Jul 2026 · Company Update / Analyst / Investor Meet
Intimation for Grant of Employee Stock Options under Bajaj Healthcare Limited Employee Stock Option Plan 202420 Jul 2026 · Company Update / General
Press Release for the quarter ended June 30, 202620 Jul 2026 · Company Update / Press Release / Media Release
Statement of Deviation & Variation for the quarter ended June 30, 202620 Jul 2026 · Company Update / Reg. 32 (1), (3) - Statement of Deviation & Variation
Monitoring Agency Report for the quarter ended June 30, 202620 Jul 2026 · Company Update / Monitoring Agency Report
Continuation of directorship of Mr. Gopalakrishnan Kesavan as Non-Executive Independent Director of the Company upon attaining the age of 75 years20 Jul 2026 · Company Update / Change in Management
Financial Results for the quarter ended June 30, 202620 Jul 2026 · Result / Financial Results
Outcome of the Board Meeting held on July 20, 202620 Jul 2026 · Board Meeting / Outcome of Board Meeting
Earnings Call Invite16 Jul 2026 · Company Update / Analyst / Investor Meet
Earnings Call Invite16 Jul 2026 · Company Update / Analyst / Investor Meet
Bajaj Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/07/2026 ,inter alia, to consider and approve the Un-audited Financial Results ....14 Jul 2026 · Board Meeting / Board Meeting
Compliance Certificate under Regulation 74(5) of SEBI (DP), Regulations, 2018 for the quarter ended June 30, 20268 Jul 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
The Company has received a recommendation from SEC-CDSCO to manufacture and market Cenobamate Tablets26 Jun 2026 · Company Update / General
Intimation for closure of Trading Window24 Jun 2026 · Insider Trading / SAST / Closure of Trading Window
Disclosure under Regulation 30 of the SEBI (LODR) Regulations, 2015 for the sale of a business unit of the Company23 Jun 2026 · Company Update / General
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Anil Jain15 Jun 2026 · Insider Trading / SAST / Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
Annual Secretarial Compliance Report30 May 2026 · Company Update / Reg.24(A)-Annual Secretarial Compliance
Intimation for Newspaper Publication10 May 2026 · Company Update / Newspaper Publication
Press Release for the quarter and year ended 31st March 20268 May 2026 · Company Update / Press Release / Media Release
Statement of Deviation & Variation for the quarter ended 31st March 20268 May 2026 · Company Update / Reg. 32 (1), (3) - Statement of Deviation & Variation
Monitoring Agency Report for the quarter ended 31st March 20268 May 2026 · Company Update / Monitoring Agency Report
Announcement under Regulation 30 of SEBI (LODR) Regulations, 2015 for the Appointment of Auditors8 May 2026 · Company Update / General
Recommend Final Dividend for the financial year 2025-26 at the rate of Rs. 1.5/- per equity share8 May 2026 · Corp Action / Dividend Updates
Financial Results for the quarter and financial year ended 31st March 20268 May 2026 · Result / Financial Results
Outcome of the Board Meeting8 May 2026 · Board Meeting / Outcome of Board Meeting
Intimation of approval received for listing of 20,79,409 equity shares of ?5/- each allotted pursuant to conversion of warrants issued on preferential basis7 May 2026 · Company Update / General
Bajaj Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/05/2026 ,inter alia, to consider and approve 1. Audited Financial Results ....2 May 2026 · Board Meeting / Board Meeting
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. <table border=''1px''><tr> <td>Sr. No.</td> <td>Particulars</td> <td>Details</td> ....24 Apr 2026 · Others / Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

Corporate actions

Purpose	Ex date	Record date	Payment date
Final Dividend - Rs. - 1.5000	11 Sep 2026	14 Sep 2026	—
Final Dividend - Rs. - 1.0000	19 Sep 2025	19 Sep 2025	—
Final Dividend - Rs. - 1.0000	23 Sep 2024	—	—

Board meetings

20 Jul 2026 Board Meeting - Financial Results